The BCG immunization coverage in the United Arab Emirates has displayed variability over the years, moving between 86% and 99% from 2013 to 2023, with a notable dip to 86% in 2020 and remaining steady near that lower range since then. The year-on-year variations highlight fluctuations, with a sharp decrease of 8.51% in 2020 and a slight decline thereafter. The forecasted data projects a continuous but gradual decline, with the coverage expected to drop to 84% by 2028. The average CAGR over the past five years has been -1.97%, indicating a downward trend.
Future trends to watch for include the impact of healthcare policies to enhance immunization rates, potential public health challenges, and demographic shifts that could either mitigate or exacerbate the decline in coverage. Monitoring these factors will be essential for maintaining and potentially improving BCG immunization rates.
Latest reports
US Vaccine Market Report- Q1 2025
The US vaccine market in the first quarter of 2025 is characterized by significant growth and innovation, driven by technological advancements, strategic government...
China Vaccine Market Report- Q1 2025
The first quarter of 2025 marked a period of dynamic change and growth for the vaccine market in China, driven by strategic government...
Japan Vaccine Market Report- Q4 2024
In the fourth quarter of 2024, Japan's vaccine market saw significant developments across various segments, with a focus on technological innovation and strategic...
Germany Vaccine Market Report- Q4 2024
In the fourth quarter of 2024, the vaccine market in Germany experienced significant transformations driven by technological advancements and strategic collaborations. The focus...
India Vaccine Market Report- Q4 2024
The vaccine market in India witnessed significant developments in Q4 2024, driven by strategic initiatives and governmental policies aimed at bolstering production and...
UK Vaccine Market Report- Q4 2024
The UK vaccine market in Q4 2024 experienced notable developments driven by legal, economic, and strategic factors. The quarter was marked by significant...
France Vaccine Market Report- Q4 2024
The fourth quarter of 2024 marked a transformative period for the vaccine market in France, characterized by significant strategic developments, technological advancements, and...
Canada Vaccine Market Report- Q4 2024
The Canadian vaccine market in the fourth quarter of 2024 is characterized by strategic partnerships, significant investment trends, the emergence of novel vaccine...
Brazil Vaccine Market Report- Q4 2024
The fourth quarter of 2024 witnessed significant developments in the Brazilian vaccine market, underscored by a combination of technological advancements, strategic partnerships, and...
Italy Vaccine Market Report- Q4 2024
The fourth quarter of 2024 marked significant developments in the vaccine market in Italy, with a notable focus on vaccine production, distribution, and...